2. Cell Cycle/DNA Damage Epigenetics Apoptosis
  3. PARP Topoisomerase Apoptosis
  4. TOPOI/PARP-1-IN-1

TOPOI/PARP-1-IN-1 (Compound B6) is an orally active, low cytotoxic TOPOI/PARP dual inhibitor with an IC50 value of 0.09 μM for PARP1. TOPOI/PARP-1-IN-1 can effectively inhibit the proliferation and migration of cancer cells. TOPOI/PARP-1-IN-1 also causes cell cycle arrest in the G0/G1 phase and induces apoptosis. The tumor growth inhibition rate (TGI) of TOPOI/PARP-1-IN-1 in mice is 75.4%.

商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。

TOPOI/PARP-1-IN-1

TOPOI/PARP-1-IN-1 構造式

CAS 番号 : 2948352-16-5

容量 在庫状況
50 mg   お問い合わせ  
100 mg   お問い合わせ  
250 mg   お問い合わせ  

* アイテムを追加する前、数量をご選択ください

This product is a controlled substance and not for sale in your territory.

TOPOI/PARP-1-IN-1 関連抗体

Top Publications Citing Use of Products

PARP アイソフォーム固有の製品をすべて表示:

すべてのアイソフォームを表示
PARP PARP1 PARP2 PARP3 PARP4 TNKS1/PARP5A TNKS2/PARP5B PARP7 PARP10 PARP14 PARP15 PARP12 PARP16

Topoisomerase アイソフォーム固有の製品をすべて表示:

すべてのアイソフォームを表示
Topoisomerase Topo I Topo II DNA gyrase

  • 生物活性

  • 純度とドキュメンテーション

  • 参考文献

  • カスタマーレビュー

製品説明

TOPOI/PARP-1-IN-1 (Compound B6) is an orally active, low cytotoxic TOPOI/PARP dual inhibitor with an IC50 value of 0.09 μM for PARP1. TOPOI/PARP-1-IN-1 can effectively inhibit the proliferation and migration of cancer cells. TOPOI/PARP-1-IN-1 also causes cell cycle arrest in the G0/G1 phase and induces apoptosis. The tumor growth inhibition rate (TGI) of TOPOI/PARP-1-IN-1 in mice is 75.4%[1].

IC50 & Target

IC50: 0.09 μM (PARP1)[1].
Cellular Effect
Cell Line Type Value Description References
A549 IC50
9.48 μM
Compound: B6
Antiproliferative activity against human A549 cells assessed as inhibition of cell growth incubated for 48 hrs by MTT assay
Antiproliferative activity against human A549 cells assessed as inhibition of cell growth incubated for 48 hrs by MTT assay
[PMID: 38554475]
HGC-27 IC50
2.49 μM
Compound: B6
Antiproliferative activity against human HGC-27 cells assessed as inhibition of cell growth incubated for 48 hrs by MTT assay
Antiproliferative activity against human HGC-27 cells assessed as inhibition of cell growth incubated for 48 hrs by MTT assay
[PMID: 38554475]
HeLa IC50
7.21 μM
Compound: B6
Antiproliferative activity against human HeLa cells assessed as inhibition of cell growth incubated for 48 hrs by MTT assay
Antiproliferative activity against human HeLa cells assessed as inhibition of cell growth incubated for 48 hrs by MTT assay
[PMID: 38554475]
HepG2 IC50
3.8 μM
Compound: B6
Antiproliferative activity against human HepG2 cells assessed as inhibition of cell growth incubated for 48 hrs by MTT assay
Antiproliferative activity against human HepG2 cells assessed as inhibition of cell growth incubated for 48 hrs by MTT assay
[PMID: 38554475]
L02 IC50
> 64 μM
Compound: B6
Antiproliferative activity against human L02 cells assessed as inhibition of cell growth incubated for 48 hrs by MTT assay
Antiproliferative activity against human L02 cells assessed as inhibition of cell growth incubated for 48 hrs by MTT assay
[PMID: 38554475]
体外実験

TOPOI/PARP-1-IN-1 (1.25-5 μM; 48 h) inhibits the proliferation and migration of HGC-27 cells in a dose-dependent manner[1].
TOPOI/PARP-1-IN-1 (1.25-5 μM; 24 h) induces apoptosis in a dose-dependent manner in HGC-27 cells[1].
TOPOI/PARP-1-IN-1 induces DNA damage and decreases TOPOI expression in HGC-27 cells[1].
TOPOI/PARP-1-IN-1 exhibits anti-tumor activity, with IC50 values of 7.21 μM, 9.48 μM, 3.80 μM and 2.49 μM against HeLa, A549, HepG-2 and HGC-27 cells, respectively[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

TOPOI/PARP-1-IN-1 関連抗体

Cell Proliferation Assay[1]

Cell Line: HGC-27 cells
Concentration: 1.25, 2.5, 5 μM
Incubation Time: 48 h
Result: Demonstrated dose-dependent inhibitory effect of B6 on the clonogenicity of HGC-27 cells.

Apoptosis Analysis[1]

Cell Line: HGC-27 cells
Concentration: 1.25, 2.5, 5 μM
Incubation Time: 24 h
Result: Induced 15.5%, 43.1% and 76.0% of cell apoptosis when the concentrations were 1.25, 2.5, and 5 μM respectively.
体内実験

TOPOI/PARP-1-IN-1 (40 mg/kg; p.o.; once every two days, for a total of 17 days) inhibits HGC-27 tumor growth in xenograft tumor mice model[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: Female BALB/c nude mice (xenograft tumor model of HGC-2 cells)[1].
Dosage: 40 mg/kg
Administration: Oral administration; once every two days, for a total of 17 days
Result: Exhibited tumor growth inhibition rate (TGI) of 75.4% in mice.
分子量

718.52

分子式

C36H38Br2N4O2
CAS 番号
SMILES

O=C(N([C@@]([H])([C@]1(CCCN2CCC3)[H])CCCC4=NC(C=C(C(Br)=C5)Br)=C5N4)C[C@@]3([H])[C@@]12[H])OCC6C7=C(C8=C6C=CC=C8)C=CC=C7
輸送条件

Room temperature in continental US; may vary elsewhere.
保管条件

Please store the product under the recommended conditions in the Certificate of Analysis.
純度とドキュメンテーション
参考文献
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.

TOPOI/PARP-1-IN-1 Related Classifications

  • Molarity Calculator

  • Dilution Calculator

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

質量   濃度   体積   分子量 *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

一般には略語で表示されます：C1V1 = C2V2

濃度 （開始） × 体積 （開始） = 濃度 （終了） × 体積 （終了）
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Keywords:

TOPOI/PARP-1-IN-12948352-16-5PARPTopoisomeraseApoptosispoly ADP ribose polymerase HGC-27cancertumorHeLaA549HepG-2apoptosisTGIInhibitorinhibitorinhibit

最近チェックした製品:

オンラインお問い合わせ

Your information is safe with us. * Required Fields.

製品名

  

カスタマ需要量 *

お名前 *

 

タイトル

メールアドレス *

 

電話番号 *

デパートメント

 

組纖名 *

市区町村

都道府県

国或いは地域 *

      

必ず会社名を記載ください。個人への返信は行いません。

備考

バルクお問い合わせ

Inquiry Information

製品名:
TOPOI/PARP-1-IN-1
製品番号:
HY-158138
数量:
MCE 日本正規代理店:

カスタマーレビュー

Thank You for Your Feedback!

Request for HNMR Report

Please fill out this form to request the QC report. We will send it to your Email address shortly.

Your information is safe with us. * Required Fields.

製品名

  

Lot #

お名前 *

 

メールアドレス *

電話番号 *

 

部門 *

組纖名 *

 

国或いは地域 *

備考

Request for HNMR Report

We have received your request and will respond to you as soon as possible.